A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

NCT07388498 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncontrolled Gout

Interventions

DRUG: Pegloticase
DRUG: Methotrexate

Sponsor

Amgen